A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Matteo M. Trucco, Christian F. Meyer, Katherine A. Thornton, Preeti Shah, Allen R. Chen, Breelyn A. Wilky, Maria A. Carrera-Haro, Lillian C. Boyer, Margaret F. Ferreira, Umber Shafique, Jonathan D. Powell, David M. Loeb

ABSTRACT

Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy. Methods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20 mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30 mg/m2 monthly). Results: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315 days (range 27-799). Response rate, defined as stable disease or better for 60 days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response. Conclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx. More... »

PAGES

21

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9

DOI

http://dx.doi.org/10.1186/s13569-018-0107-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106441984

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30410720


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sylvester Comprehensive Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.419791.3", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Trucco", 
        "givenName": "Matteo M.", 
        "id": "sg:person.01271362401.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271362401.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyer", 
        "givenName": "Christian F.", 
        "id": "sg:person.0671233643.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671233643.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dana\u2013Farber Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Dana Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thornton", 
        "givenName": "Katherine A.", 
        "id": "sg:person.01060373227.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060373227.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Akan Biosciences, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Preeti", 
        "id": "sg:person.01320446625.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320446625.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Allen R.", 
        "id": "sg:person.011331130342.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331130342.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sylvester Comprehensive Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.419791.3", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilky", 
        "givenName": "Breelyn A.", 
        "id": "sg:person.01100106752.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100106752.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Columbia University", 
          "id": "https://www.grid.ac/institutes/grid.21729.3f", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Columbia University College of Physicians and Surgeons, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carrera-Haro", 
        "givenName": "Maria A.", 
        "id": "sg:person.01213546220.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213546220.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boyer", 
        "givenName": "Lillian C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferreira", 
        "givenName": "Margaret F.", 
        "id": "sg:person.01327774620.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327774620.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafique", 
        "givenName": "Umber", 
        "id": "sg:person.0652503720.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652503720.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins University", 
          "id": "https://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Powell", 
        "givenName": "Jonathan D.", 
        "id": "sg:person.01162106561.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162106561.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Albert Einstein College of Medicine", 
          "id": "https://www.grid.ac/institutes/grid.251993.5", 
          "name": [
            "Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA", 
            "Department of Pediatrics, Albert Einstein College of Medicine, Children\u2019s Hospital at Montefiore, 3411 Wayne Ave., Room 910, 10467, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loeb", 
        "givenName": "David M.", 
        "id": "sg:person.0637477735.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637477735.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ijc.25519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002828710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2013/480713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004495775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-14-756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014345450", 
          "https://doi.org/10.1186/1471-2407-14-756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/jct.2014.54040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018847250"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.28083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019909903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.6176", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020789383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0013943", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030045270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.6920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030454788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13577140500287024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030926841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13577140500287024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030926841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.35.6329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043104827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5483/bmbrep.2007.40.6.1069", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045821415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-13-3456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048644685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050673398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079022612", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.30589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084010620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2017.242", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090931195", 
          "https://doi.org/10.1038/onc.2017.242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2016-0474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091330789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.22655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092984548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11523-017-0539-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092996951", 
          "https://doi.org/10.1007/s11523-017-0539-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy.\nMethods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20\u00a0mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30\u00a0mg/m2 monthly).\nResults: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315\u00a0days (range 27-799). Response rate, defined as stable disease or better for 60\u00a0days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response.\nConclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13569-018-0107-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2458242", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1046367", 
        "issn": [
          "2045-3329"
        ], 
        "name": "Clinical Sarcoma Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas", 
    "pagination": "21", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1febf2658cc89bda2143eb9aae0b4720d4cf534096a9296c78c62ef9775a42be"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30410720"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101577890"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13569-018-0107-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106441984"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13569-018-0107-9", 
      "https://app.dimensions.ai/details/publication/pub.1106441984"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78970_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13569-018-0107-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13569-018-0107-9'


 

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      21 PREDICATES      48 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13569-018-0107-9 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N6e57e166df7d4a4aa8c2d9ac5abe05ee
4 schema:citation sg:pub.10.1007/s11523-017-0539-9
5 sg:pub.10.1038/onc.2017.242
6 sg:pub.10.1186/1471-2407-14-756
7 https://app.dimensions.ai/details/publication/pub.1079022612
8 https://doi.org/10.1002/cncr.25928
9 https://doi.org/10.1002/cncr.30589
10 https://doi.org/10.1002/ijc.25519
11 https://doi.org/10.1002/ijc.28083
12 https://doi.org/10.1080/13577140500287024
13 https://doi.org/10.1155/2013/480713
14 https://doi.org/10.1158/0008-5472.can-13-3456
15 https://doi.org/10.1200/jco.2011.35.6329
16 https://doi.org/10.1371/journal.pone.0013943
17 https://doi.org/10.1634/theoncologist.2016-0474
18 https://doi.org/10.18632/oncotarget.22655
19 https://doi.org/10.18632/oncotarget.6176
20 https://doi.org/10.18632/oncotarget.6920
21 https://doi.org/10.4236/jct.2014.54040
22 https://doi.org/10.5483/bmbrep.2007.40.6.1069
23 schema:datePublished 2018-12
24 schema:datePublishedReg 2018-12-01
25 schema:description Background: Relapsed and refractory sarcomas continue to have poor survival rates. The cancer stem cell (CSC) theory provides a tractable explanation for the observation that recurrences occur despite dramatic responses to upfront chemotherapy. Preclinical studies demonstrated that inhibition of the mechanistic target of rapamycin (mTOR) sensitizes the CSC population to chemotherapy. Methods: Here we present the results of the Phase II portion of a Phase I/II clinical trial that aimed to overcome the chemoresistance of sarcoma CSC by combining the mTOR inhibitor temsirolimus (20 mg/m2 weekly) with the chemotherapeutic agent liposomal doxorubicin (30 mg/m2 monthly). Results: Fifteen patients with relapsed/refractory sarcoma were evaluable at this recommended Phase 2 dose level. The median progression free survival was 315 days (range 27-799). Response rate, defined as stable disease or better for 60 days, was 53%. Nine of the patients had been previously treated with doxorubicin. Therapy was well tolerated. In a small number of patients, pre- and post- treatment tumor biopsies were available for assessment of ALDH expression as a marker of CSCs and showed a correlation between response and decreased ALDH expression. We also found a correlation between biopsy-proven inhibition of mTOR and response. Conclusions: Our study adds to the literature supporting the addition of mTOR inhibition to chemotherapy agents for the treatment of sarcomas, and proposes that a mechanism by which mTOR inhibition enhances the efficacy of chemotherapy may be through sensitizing the chemoresistant CSC population. Further study, ideally with pre- and post-therapy assessment of ALDH expression in tumor cells, is warranted.Trial registration The trial was registered on clinicaltrials.gov (NCT00949325) on 30 July 2009. http://www.editorialmanager.com/csrj/default.aspx.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree true
29 schema:isPartOf N1ae97410052b428891d0c45fe430a3c2
30 N9611fe93292e488ea80a528db2bfc668
31 sg:journal.1046367
32 schema:name A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
33 schema:pagination 21
34 schema:productId N776377e6a486400ca44c76b3a8782ab4
35 Nb5c8bf07ea044294b024cdd1ced3d948
36 Nc8995ff50eeb4a58a4c983fec8d35975
37 Nd2bfa6403b114b549b0079c34abf76f6
38 Nd5884fb5353f4a54b6877cec7d462e48
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106441984
40 https://doi.org/10.1186/s13569-018-0107-9
41 schema:sdDatePublished 2019-04-11T13:20
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher Na20b4a846f234c1d98376705e0b0cfc1
44 schema:url https://link.springer.com/10.1186%2Fs13569-018-0107-9
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N0ced521edeb34a3da12f5fe649ffcebe rdf:first sg:person.0637477735.81
49 rdf:rest rdf:nil
50 N17d2af2283484f28806ba36dd09db8b1 rdf:first sg:person.01162106561.71
51 rdf:rest N0ced521edeb34a3da12f5fe649ffcebe
52 N1ae97410052b428891d0c45fe430a3c2 schema:issueNumber 1
53 rdf:type schema:PublicationIssue
54 N30e195eee89949a5b54aeb87ae9d6e01 rdf:first sg:person.0652503720.97
55 rdf:rest N17d2af2283484f28806ba36dd09db8b1
56 N4015d5e641d64f6b9333a9713e80f506 rdf:first sg:person.01100106752.21
57 rdf:rest Na045716d9f3846b6a70291a688b4c219
58 N5305730d65ad469b9784edbf9e036dc4 rdf:first sg:person.011331130342.94
59 rdf:rest N4015d5e641d64f6b9333a9713e80f506
60 N6ba0ec368d3b4f52bfb59903e6e4697e rdf:first sg:person.0671233643.18
61 rdf:rest Nc4460cff4dac41698a7bf49918963f65
62 N6e57e166df7d4a4aa8c2d9ac5abe05ee rdf:first sg:person.01271362401.35
63 rdf:rest N6ba0ec368d3b4f52bfb59903e6e4697e
64 N6f5a977387114a87b1a04809df630e23 rdf:first sg:person.01320446625.89
65 rdf:rest N5305730d65ad469b9784edbf9e036dc4
66 N776377e6a486400ca44c76b3a8782ab4 schema:name doi
67 schema:value 10.1186/s13569-018-0107-9
68 rdf:type schema:PropertyValue
69 N810a32a0ca2943648bad3d568dc5808c rdf:first Ne9ef580e6cd14cc6927d7841290fa1d6
70 rdf:rest Naeccaaa0f5e34847a131e8f1e060fae0
71 N9611fe93292e488ea80a528db2bfc668 schema:volumeNumber 8
72 rdf:type schema:PublicationVolume
73 Na045716d9f3846b6a70291a688b4c219 rdf:first sg:person.01213546220.84
74 rdf:rest N810a32a0ca2943648bad3d568dc5808c
75 Na20b4a846f234c1d98376705e0b0cfc1 schema:name Springer Nature - SN SciGraph project
76 rdf:type schema:Organization
77 Naeccaaa0f5e34847a131e8f1e060fae0 rdf:first sg:person.01327774620.47
78 rdf:rest N30e195eee89949a5b54aeb87ae9d6e01
79 Nb5c8bf07ea044294b024cdd1ced3d948 schema:name readcube_id
80 schema:value 1febf2658cc89bda2143eb9aae0b4720d4cf534096a9296c78c62ef9775a42be
81 rdf:type schema:PropertyValue
82 Nc4460cff4dac41698a7bf49918963f65 rdf:first sg:person.01060373227.64
83 rdf:rest N6f5a977387114a87b1a04809df630e23
84 Nc8995ff50eeb4a58a4c983fec8d35975 schema:name dimensions_id
85 schema:value pub.1106441984
86 rdf:type schema:PropertyValue
87 Nd2bfa6403b114b549b0079c34abf76f6 schema:name nlm_unique_id
88 schema:value 101577890
89 rdf:type schema:PropertyValue
90 Nd5884fb5353f4a54b6877cec7d462e48 schema:name pubmed_id
91 schema:value 30410720
92 rdf:type schema:PropertyValue
93 Ne9ef580e6cd14cc6927d7841290fa1d6 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
94 schema:familyName Boyer
95 schema:givenName Lillian C.
96 rdf:type schema:Person
97 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical and Health Sciences
99 rdf:type schema:DefinedTerm
100 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
101 schema:name Oncology and Carcinogenesis
102 rdf:type schema:DefinedTerm
103 sg:grant.2458242 http://pending.schema.org/fundedItem sg:pub.10.1186/s13569-018-0107-9
104 rdf:type schema:MonetaryGrant
105 sg:journal.1046367 schema:issn 2045-3329
106 schema:name Clinical Sarcoma Research
107 rdf:type schema:Periodical
108 sg:person.01060373227.64 schema:affiliation https://www.grid.ac/institutes/grid.65499.37
109 schema:familyName Thornton
110 schema:givenName Katherine A.
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060373227.64
112 rdf:type schema:Person
113 sg:person.01100106752.21 schema:affiliation https://www.grid.ac/institutes/grid.419791.3
114 schema:familyName Wilky
115 schema:givenName Breelyn A.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100106752.21
117 rdf:type schema:Person
118 sg:person.011331130342.94 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
119 schema:familyName Chen
120 schema:givenName Allen R.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011331130342.94
122 rdf:type schema:Person
123 sg:person.01162106561.71 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
124 schema:familyName Powell
125 schema:givenName Jonathan D.
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162106561.71
127 rdf:type schema:Person
128 sg:person.01213546220.84 schema:affiliation https://www.grid.ac/institutes/grid.21729.3f
129 schema:familyName Carrera-Haro
130 schema:givenName Maria A.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213546220.84
132 rdf:type schema:Person
133 sg:person.01271362401.35 schema:affiliation https://www.grid.ac/institutes/grid.419791.3
134 schema:familyName Trucco
135 schema:givenName Matteo M.
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271362401.35
137 rdf:type schema:Person
138 sg:person.01320446625.89 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
139 schema:familyName Shah
140 schema:givenName Preeti
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320446625.89
142 rdf:type schema:Person
143 sg:person.01327774620.47 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
144 schema:familyName Ferreira
145 schema:givenName Margaret F.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327774620.47
147 rdf:type schema:Person
148 sg:person.0637477735.81 schema:affiliation https://www.grid.ac/institutes/grid.251993.5
149 schema:familyName Loeb
150 schema:givenName David M.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637477735.81
152 rdf:type schema:Person
153 sg:person.0652503720.97 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
154 schema:familyName Shafique
155 schema:givenName Umber
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652503720.97
157 rdf:type schema:Person
158 sg:person.0671233643.18 schema:affiliation https://www.grid.ac/institutes/grid.21107.35
159 schema:familyName Meyer
160 schema:givenName Christian F.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671233643.18
162 rdf:type schema:Person
163 sg:pub.10.1007/s11523-017-0539-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092996951
164 https://doi.org/10.1007/s11523-017-0539-9
165 rdf:type schema:CreativeWork
166 sg:pub.10.1038/onc.2017.242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090931195
167 https://doi.org/10.1038/onc.2017.242
168 rdf:type schema:CreativeWork
169 sg:pub.10.1186/1471-2407-14-756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014345450
170 https://doi.org/10.1186/1471-2407-14-756
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1079022612 schema:CreativeWork
173 https://doi.org/10.1002/cncr.25928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050673398
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1002/cncr.30589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084010620
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1002/ijc.25519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002828710
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/ijc.28083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019909903
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1080/13577140500287024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030926841
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1155/2013/480713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004495775
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1158/0008-5472.can-13-3456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048644685
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jco.2011.35.6329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043104827
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1371/journal.pone.0013943 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030045270
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1634/theoncologist.2016-0474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091330789
192 rdf:type schema:CreativeWork
193 https://doi.org/10.18632/oncotarget.22655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092984548
194 rdf:type schema:CreativeWork
195 https://doi.org/10.18632/oncotarget.6176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020789383
196 rdf:type schema:CreativeWork
197 https://doi.org/10.18632/oncotarget.6920 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030454788
198 rdf:type schema:CreativeWork
199 https://doi.org/10.4236/jct.2014.54040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018847250
200 rdf:type schema:CreativeWork
201 https://doi.org/10.5483/bmbrep.2007.40.6.1069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045821415
202 rdf:type schema:CreativeWork
203 https://www.grid.ac/institutes/grid.21107.35 schema:alternateName Johns Hopkins University
204 schema:name Akan Biosciences, Gaithersburg, MD, USA
205 Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
206 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
207 rdf:type schema:Organization
208 https://www.grid.ac/institutes/grid.21729.3f schema:alternateName Columbia University
209 schema:name Columbia University College of Physicians and Surgeons, New York, NY, USA
210 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
211 rdf:type schema:Organization
212 https://www.grid.ac/institutes/grid.251993.5 schema:alternateName Albert Einstein College of Medicine
213 schema:name Department of Pediatrics, Albert Einstein College of Medicine, Children’s Hospital at Montefiore, 3411 Wayne Ave., Room 910, 10467, Bronx, NY, USA
214 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.419791.3 schema:alternateName Sylvester Comprehensive Cancer Center
217 schema:name Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
218 Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
219 Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
220 rdf:type schema:Organization
221 https://www.grid.ac/institutes/grid.65499.37 schema:alternateName Dana–Farber Cancer Institute
222 schema:name Dana Farber Cancer Institute, Boston, MA, USA
223 Division of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
224 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...